3.20 (-%)
As of Oct 31, 2024
Source:
Polypid Ltd. is a Phase 3 clinical-stage biopharmaceutical company focused on developing targeted, locally administered and prolonged-release therapeutics using our proprietary PLEX technology.
Country | ISRAEL |
Headquarters | petach tikva, israel |
Phone Number | (908) 858-5995 |
Industry | manufacturing |
CEO | Dikla Czaczkes Akselbrad |
Website | www.polypid.com |